Musk sought settlement with OpenAI before Oakland trial, filing shows

Elon Musk contacted OpenAI President Greg Brockman about a possible settlement two days before the trial began in Oakland federal court, highlighting an intensifying legal dispute over OpenAI's shift from nonprofit to for-profit structure. Musk is seeking governance changes and $150 billion in damages from OpenAI and Microsoft, while testimony from Sam Altman, Brockman and Satya Nadella is expected later this month. The case is expected to run for several weeks, with a verdict possible by mid-May.

Analysis

The market should treat this less as a binary legal event and more as an overhang on MSFT’s governance discount. Even if Microsoft is not the primary defendant, any discovery or testimony that ties it more tightly to OpenAI’s capital structure and control rights raises the probability of incremental regulatory scrutiny, softer partnership terms, or headline risk around future model commercialization. That matters because the equity story for MSFT AI is partly about optionality with limited visible liability; litigation can reprice that optionality even without a near-term earnings hit.

The second-order effect is on bargaining power inside the AI ecosystem. A protracted trial makes OpenAI’s structure look more contested, which may increase the premium demanded by talent, cloud partners, and enterprise customers who want contractual stability rather than governance drama. In that sense, competitors with cleaner governance and less founder-state conflict could gain relative share in enterprise deployments over the next 6-12 months, even if OpenAI remains the technical leader.

The near-term catalyst path is mostly legal, not fundamental: testimony from Altman/Brockman/Nadella can widen the headline volatility window into mid-May. The tail risk is that the court record creates a durable narrative that OpenAI’s commercialization path was always under question, which could compress the multiple investors are willing to assign to MSFT’s AI contribution. The contrarian view is that the market may be overestimating the direct financial exposure and underestimating how quickly this becomes a governance premium problem rather than a damages problem.

Key Decisions for Investors

• Trim MSFT into testimony weeks and re-add on post-hearing weakness: the setup is a volatility event, not a thesis breaker; use any 3-5% drawdown as an opportunity only if the court record does not broaden regulatory risk.
• Buy short-dated MSFT put spreads into the mid-May verdict window (e.g., 2-6 week tenor): limited premium outlay to express headline/tape risk while capping downside if the market shrugs off the trial.
• Pair trade: long a cleaner AI infrastructure beneficiary versus short MSFT on a relative basis for 1-3 months; the goal is to isolate governance discount risk rather than bet against AI capex itself.
• If implied volatility spikes materially ahead of the key witnesses, sell MSFT call spreads against existing longs to monetize legal-event premium; risk/reward improves if the stock already prices in a bad headline cycle.
• Monitor for a multi-week rally in alternative enterprise AI names if discovery weakens OpenAI’s governance narrative; that is the higher-quality second-order trade than chasing legal beta in MSFT.